This meeting took place in 2013



For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Advances in the Knowledge and Treatment of Autoimmunity (Z2)


Organizer(s) Juan Rivera, Virginia Pascual and David M. Lee
April 4—9, 2013
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Abstract Deadline: Dec 4, 2012
Late Abstract Deadline: Jan 4, 2013
Scholarship Deadline: Dec 4, 2012
Early Registration Deadline: Feb 4, 2013

Sponsored by Biogen Idec, MedImmune and Novo Nordisk A/S


Summary of Meeting:
Understanding the mechanisms by which tolerance is induced and circumvented is important for the development of new therapies for autoimmune disorders. While significant progress has been made in understanding the basic processes of both central and peripheral tolerance, the integration of these mechanisms in the context of the pathogenesis of autoimmunity is still in its infancy. In the past few years, considerable effort has been made in bringing together the fundamental mechanisms, the genetics and genomics, the cellular players, and the clinical features of disease towards developing novel therapeutic strategies. These efforts have also advanced our understanding of the pathogenesis of autoimmunity and revealed new players and potential therapeutic strategies in treatment of autoimmunity. The goal of this Keystone Symposia meeting on Advances in the Knowledge and Treatment of Autoimmunity is to bring together scientists and clinicians to discuss what we are learning from the information obtained from mouse models, patient studies and the use of novel targeted therapies. Both common and unique immune-mediated mechanisms leading to autoimmune diseases will be highlighted. The meeting will cover advances in genomic and cellular approaches, biomarker discovery, and in targeted therapies. The accompanying workshops will be designed to promote interactions and collaborations between academic and R & D scientists to respond to the challenges in this area. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Immunopathology of Type 1 Diabetes, which will share a keynote session and two plenary sessions with this meeting.

View Meeting Program

Scholarships/Awards

Biogen Idec ECITA Scholarship Recipients

Jonathan A. Deane
Genomics Institute of the Novartis Research Foundation, USA

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Braxton L. Jamison
University Texas, San Antonio, USA

National Institute of Allergy and Infectious Diseases (NIAID)/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Scholarship Recipients

Tom A. Barr
University of Edinburgh, UK

Simone Caielli
Baylor Institute for Immunology Research, USA

Carla M. Cuda
Northwestern University, USA

Xuezhi Dai
Seattle Childrens' Research Institute, USA

Silvia Preite
National Institutes of Health, USA

Rushika C. Wirasinha
Garvan Institute, Australia